Venture Cafe – Innovation in Cardiac Intervention

This LEGO® Serious Play® workshop is designed for business leaders seeking innovative decision-making approaches through hands-on building and storytelling. The neuroscience-based method combines analytical thinking with intuition, using 3D models and metaphors to help participants discover authentic solutions during pivotal organizational moments. You’ll build models representing your challenges, share stories through your creations, and connect with fellow participants in new ways. This immersive experience unlocks innovation and hidden insights by tapping into knowledge you didn’t know you had. No special skills required—just bring curiosity and experience how simple bricks can unlock extraordinary ideas through serious fun.

As part of ASU’s longstanding collaboration with the Mastercard Foundation Program, ASU’s J. Orin Edson Entrepreneurship + Innovation Institute (Edson E+I) is showcasing the creative products of two founders from the 2026 cohort. Visit the Edson E+I innovation space on the ground floor of the 850 PBC building from 4:30 to 5:30pm to engage with these founders, learn about the products and stories, as well as the impact being created through this innovative collaboration.

Arrive early to Venture Café Phoenix for your chance to connect with Uko Okon, Founder of Better Growth LLC. Come gain insights on a three-instrument Retention Intelligence System that replaces the exit interview ith something that actually works.

Mentor Hours meetings begin at 4:30pm and run in 15-minute slots

Arrive early to Venture Café Phoenix for your chance to connect with Raymond Singh, President & Senior Financial Advisor of Innovative Retirement Solutions. Come gain insights wealth and retirement planning. 

Mentor Hours meetings begin at 4:30pm and run in 15-minute slots

Sponsored by: Arizona Commerce Authority & Center for Entrepreneurial Innovation, In Partnership with: Alimental Business

W. L. Gore & Associates will present an overview of innovations within its Cardiac Business Unit, with a focus on structural heart and interventional cardiology therapies. The discussion will highlight Gore’s